Related Experiment Videos
Fabrication of a keratoprosthesis
M G Doane1, C H Dohlman, G Bearse
1Schepens Eye Research Institute, Boston, MA 02114, USA.
Cornea
|March 1, 1996
Summary
Polymethylmethacrylate (PMMA) keratoprosthesis devices offer a vision restoration option for patients with opaque corneas unsuitable for traditional transplants. Two designs are presented for varying ocular surface conditions, aiming to improve sight where other methods fail.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Medical Device Engineering
Background:
- Corneal opacity significantly impairs vision, often rendering conventional corneal transplantation unsuitable.
- Keratoprostheses serve as artificial corneas, providing a potential solution for severe corneal blindness.
- Polymethylmethacrylate (PMMA) is a durable and optically clear material suitable for intraocular devices.
Purpose of the Study:
- To describe the design, fabrication, and optical performance of two novel PMMA keratoprosthesis variations.
- To evaluate the suitability of different keratoprosthesis designs for specific ocular surface conditions.
- To offer a viable alternative for patients with opaque corneas and poor prognosis for standard transplants.
Main Methods:
- Detailed design specifications for two PMMA keratoprosthesis types were developed.
- Fabrication processes for the described PMMA devices were outlined.
- Optical testing methodologies were employed to assess the visual performance of the keratoprostheses.
Main Results:
- Two distinct PMMA keratoprosthesis designs were successfully created and optically tested.
- Type 1: A twin-plate collarbutton design for eyes with adequate tear production.
- Type 2: A modified design with an anterior cylinder for end-stage dry eyes with closed eyelids.
Conclusions:
- PMMA keratoprostheses represent a promising approach for vision restoration in complex corneal diseases.
- The described designs cater to different ocular surface environments, enhancing applicability.
- These devices offer hope for usable vision in patients with limited conventional treatment options.